Differential benefits and outcomes of tirofiban vs abciximab for acute coronary syndromes in current clinical practice. [electronic resource]
Producer: 20030425Description: 211-8 p. digitalISSN:- 0003-3197
- Abciximab
- Aged
- Angina, Unstable -- drug therapy
- Antibodies, Monoclonal -- therapeutic use
- Humans
- Immunoglobulin Fab Fragments -- therapeutic use
- Middle Aged
- Myocardial Infarction -- drug therapy
- Platelet Aggregation Inhibitors -- therapeutic use
- Platelet Glycoprotein GPIIb-IIIa Complex -- antagonists & inhibitors
- Retrospective Studies
- Syndrome
- Tirofiban
- Tyrosine -- analogs & derivatives
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.